Intrinsic Value
Titan Pharmaceuticals, Inc. (TTNP)
$1.05
+0.03 (+2.94%)
| Enterprise Value | -8,697,259.79 |
|---|---|
| Net Debt | -5.74 |
| Equity Value | -8,697,254.05 |
| Shares Outstanding | 9.73 |
| Equity Value Per Share | -893,859.61 |
Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt